{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:23:08Z","timestamp":1785424988811,"version":"3.56.0"},"reference-count":28,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo, Turin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/00d1b1c41","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Fondazione Diabete Torino ONLUS"},{"DOI":"10.13039\/501100003407","name":"Italian Ministry for Education, University and Research","doi-asserted-by":"crossref","award":["20224TWKNJ"],"award-info":[{"award-number":["20224TWKNJ"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background\/Objectives: Diabetic retinopathy (DR) is a leading cause of preventable visual impairment, and systematic screening is essential to detect sight-threatening stages before symptoms occur. However, long-term real-world evidence on visual outcomes from structured screening programmes remains limited. This study evaluates, in a retrospective analysis of routinely collected clinical data, the real-life visual outcomes of screening for and treating sight-threatening DR, based on 32 years of data collected in a purpose-built centre implementing the 1990 European Working Party recommendations for screening. Methods: Screening was performed by retinal photography between 1991 and 2022 in 18,161 patients (63,289 screening episodes). Diabetes specialists graded photographs, referring patients to ophthalmologists when needed. The 10-year trajectories of visual acuity (VA) were assessed in patients with different stages of retinopathy and macular involvement at first screening. Results: At first screening, two-thirds of patients had no DR, 15% had mild DR, and the remainder had referable DR or a non-assessable fundus. There was no difference by sex. Patients with more severe DR at first screening had lower VA, but this did not worsen over 10 years. Median VA in 514 patients treated with panretinal photocoagulation for pre-proliferative or proliferative DR changed from 0.10 logMAR (7\u20138\/10) to 0.15 (6\u20138\/10), 1874 \u00b1 1252 days after treatment. In 823 patients photocoagulated for diabetic macular edema, median VA remained 0.10 logMAR (7\u20138\/10) before treatment and 1998 \u00b1 1288 days after treatment. Conclusions: Screening for sight-threatening DR using European Working Party recommendations was feasible in everyday practice and was associated with long-term preservation of visual acuity and a low incidence of severe visual loss.<\/jats:p>","DOI":"10.3390\/medsci14030355","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:49:33Z","timestamp":1782712173000},"page":"355","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thirty-Two Years Screening for Diabetic Retinopathy in a Single Centre: An Assessment of Visual Outcomes"],"prefix":"10.3390","volume":"14","author":[{"given":"Francesco","family":"Codic\u00e8","sequence":"first","affiliation":[{"name":"AI and Computational Biomedicine Unit, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3288-0631","authenticated-orcid":false,"given":"Tiziana","family":"Sanavia","sequence":"additional","affiliation":[{"name":"AI and Computational Biomedicine Unit, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Trento","sequence":"additional","affiliation":[{"name":"Diabetic Retinopathy Centre, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Striglia","sequence":"additional","affiliation":[{"name":"Diabetic Retinopathy Centre, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatolie","family":"Baltatescu","sequence":"additional","affiliation":[{"name":"Diabetic Retinopathy Centre, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Fariselli","sequence":"additional","affiliation":[{"name":"AI and Computational Biomedicine Unit, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Montanaro","sequence":"additional","affiliation":[{"name":"Diabetic Retinopathy Centre, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3407-6017","authenticated-orcid":false,"given":"Massimo","family":"Porta","sequence":"additional","affiliation":[{"name":"Diabetic Retinopathy Centre, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1111\/dom.16588","article-title":"Global, regional and national burden of blindness and vision loss attributable to diabetic retinopathy, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"27","author":"Pan","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","article-title":"Guidelines on diabetic eye care: The International Council of Ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings","volume":"125","author":"Wong","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes (2026). 12. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes\u20142026. Diabetes Care, 49, S261\u2013S276.","DOI":"10.2337\/dc26-S012"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00592-021-01687-w","article-title":"The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges","volume":"58","author":"Scanlon","year":"2021","journal-title":"Acta Diabetol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1464-5491.1993.tb00120.x","article-title":"The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy","volume":"10","author":"Agardh","year":"1993","journal-title":"Diabet. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1034\/j.1600-0420.2000.078004374.x","article-title":"Screening and prevention of diabetic blindness","volume":"78","author":"Stefansson","year":"2000","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/(SICI)1096-9136(199709)14:9<732::AID-DIA474>3.0.CO;2-J","article-title":"New blindness in diabetes reduced by more than one-third in Stockholm County","volume":"14","author":"Backlund","year":"1994","journal-title":"Diabet. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Retinopathy Working Party (1991). A protocol for screening for diabetic retinopathy in Europe. Diabet. Med., 8, 263\u2013267.","DOI":"10.1111\/j.1464-5491.1991.tb01583.x"},{"key":"ref_9","unstructured":"Kohner, E.M., and Porta, M. (1992). Screening for Diabetic Retinopathy in Europe: A Field Guidebook, World Health Organization Regional Office for Europe."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s001250050867","article-title":"Practical application of the European Field Guide in screening retinopathy by using ophthalmoscopy and 35 mm retinal slides","volume":"41","author":"Gibbins","year":"1998","journal-title":"Diabetologia"},{"key":"ref_11","first-page":"37","article-title":"SEE (Save Eyes in Europe): The London protocol in software","volume":"15","author":"Sivieri","year":"1995","journal-title":"G. Ital. Diabetol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0001-2092(06)62465-4","article-title":"The millennium bug. Do we have the right antibiotics?","volume":"69","author":"Remmert","year":"1999","journal-title":"AORN J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"ETDRS Research Group (1991). Grading diabetic retinopathy from stereoscopic colour fundus photographs\u2014An extension of the modified Airlie House classification. ETDRS Report No 10. Ophthalmology, 98, 786\u2013806.","DOI":"10.1016\/S0161-6420(13)38012-9"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"ETDRS Research Group (1991). Early photocoagulation for diabetic retinopathy. Ophthalmology, 98, 766\u2013785.","DOI":"10.1016\/S0161-6420(13)38011-7"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"ETDRS Research Group (1995). Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no 19. Arch. Ophthalmol., 113, 1144\u20131155.","DOI":"10.1001\/archopht.1995.01100090070025"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0002-9394(14)72328-1","article-title":"Mean visual acuity (letter)","volume":"111","author":"Holladay","year":"1991","journal-title":"Am. J. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2337\/dc13-2101","article-title":"Estimating the delay between onset and diagnosis of type 2 diabetes from the time-course of retinopathy prevalence","volume":"37","author":"Porta","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinic diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1034\/j.1600-0420.2002.800315.x","article-title":"A small number of older type 2 diabetic patients end up visually impaired despite regular photographic screening and laser treatment for diabetic retinopathy","volume":"80","author":"Holm","year":"2002","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_20","first-page":"e571","article-title":"Outcome of cataract surgery in eyes with diabetic retinopathy: A Swedish national cataract register report","volume":"100","author":"Montan","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/j.jcrs.0000000000001167","article-title":"Comparison of cataract surgery outcomes in patients with type 1 vs type 2 diabetes mellitus and patients without diabetes mellitus","volume":"49","author":"Xia","year":"2023","journal-title":"J. Cataract Refract Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e208035","DOI":"10.1001\/jamanetworkopen.2020.8035","article-title":"Association of cataract surgery with risk of diabetic retinopathy among Asian participants in the Singapore Epidemiology of Eye Diseases Study","volume":"3","author":"Tham","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Diabetic Retinopathy Study Research Group (1981). Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology, 88, 583\u2013600.","DOI":"10.1016\/S0161-6420(81)34978-1"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1038\/s41433-024-03078-1","article-title":"Referrals for proliferative diabetic retinopathy from two UK diabetic retinopathy screening services: A 10-year analysis of visual outcomes, requirement for vitrectomy, and mortality","volume":"38","author":"Sadiq","year":"2024","journal-title":"Eye"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1373\/clinchem.2003.024802","article-title":"IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: A method-comparison study","volume":"50","author":"Hoelzel","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/bjophthalmol-2019-315333","article-title":"Progression of retinopathy and incidence of cardiovascular disease: Findings from the Chronic Renal Insufficiency Cohort Study","volume":"105","author":"Grunwald","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00592-021-01671-4","article-title":"Factors associated with non-attendance in the Irish national diabetic retinopathy screening programme (INDEAR study report no. 2)","volume":"58","author":"Kelly","year":"2021","journal-title":"Acta Diabetol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2147\/OPTH.S261629","article-title":"The evolution of diabetic retinopathy screening programmes: A chronology of retinal photography from 35 mm slides to artificial intelligence","volume":"14","author":"Huemer","year":"2020","journal-title":"Clin. Ophthalmol."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/3\/355\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:29:24Z","timestamp":1782966564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/3\/355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medsci14030355"],"URL":"https:\/\/doi.org\/10.3390\/medsci14030355","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]}}}